{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:40:42Z","timestamp":1792424442995,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Health Research Project of Pudong New Area Health Commission in Shanghai","award":["PW2023A-67"],"award-info":[{"award-number":["PW2023A-67"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-28608-2","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:25:08Z","timestamp":1784784308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ovarian cancer in Asia: incidence, mortality in 2022, and future projections to 2050"],"prefix":"10.1186","volume":"26","author":[{"given":"Yu","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"3","key":"28608_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"Cancer J Clin"},{"key":"28608_CR2","doi-asserted-by":"publisher","unstructured":"Wei Y-F, Ning L, Xu Y-L, et al. Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017. eClinicalMedicine. 2025;79. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102983.","DOI":"10.1016\/j.eclinm.2024.102983"},{"key":"28608_CR3","doi-asserted-by":"publisher","unstructured":"Wu Y, Sun W, Xin X, Wang W, Zhang D. Age at last birth and risk of developing epithelial ovarian cancer: a meta-analysis. Biosci Rep. 2019;39(9). https:\/\/doi.org\/10.1042\/bsr20182035.","DOI":"10.1042\/bsr20182035"},{"issue":"4","key":"28608_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41416-024-02924-z","volume":"132","author":"MA Merritt","year":"2025","unstructured":"Merritt MA, Abe SK, Islam MR, et al. Reproductive factors and risk of epithelial ovarian cancer: results from the Asia Cohort Consortium. Br J Cancer. 2025;132(4):361\u201370. https:\/\/doi.org\/10.1038\/s41416-024-02924-z.","journal-title":"Br J Cancer"},{"issue":"11","key":"28608_CR5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamasurg.2023.4164","volume":"158","author":"RM Kahn","year":"2023","unstructured":"Kahn RM, Gordhandas S, Godwin K, et al. Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review. JAMA Surg. 2023;158(11):1204\u201311. https:\/\/doi.org\/10.1001\/jamasurg.2023.4164.","journal-title":"JAMA Surg"},{"issue":"10","key":"28608_CR6","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/s41416-022-01704-x","volume":"126","author":"E di Martino","year":"2022","unstructured":"di Martino E, Smith L, Bradley SH, et al. Incidence trends for twelve cancers in younger adults-a rapid review. Br J Cancer. 2022;126(10):1374\u201386. https:\/\/doi.org\/10.1038\/s41416-022-01704-x.","journal-title":"Br J Cancer"},{"issue":"4","key":"28608_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41416-024-02924-z","volume":"132","author":"MA Merritt","year":"2025","unstructured":"Merritt MA, Abe SK, Islam MR, et al. Reproductive factors and risk of epithelial ovarian cancer: results from the Asia Cohort Consortium. Br J Cancer. 2025;132(4):361\u201370. https:\/\/doi.org\/10.1038\/s41416-024-02924-z.","journal-title":"Br J Cancer"},{"issue":"1","key":"28608_CR8","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1186\/s12889-024-18858-3","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu Y, Shi W, Mubarik S, Wang F. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis. BMC Public Health. 2024;24(1):1349. https:\/\/doi.org\/10.1186\/s12889-024-18858-3.","journal-title":"BMC Public Health"},{"issue":"4","key":"28608_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00432-025-06188-9","volume":"151","author":"AAAA Al Ali","year":"2025","unstructured":"Al Ali AAAA, Al Ali MMA, El-Shourbagy DMA-H, et al. Genetic characterization of BRCA1 and BRCA2 variants in cancer and high-risk family screening cohorts in the UAE population. J Cancer Res Clin Oncol. 2025;151(4):146. https:\/\/doi.org\/10.1007\/s00432-025-06188-9.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"28608_CR10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12905-025-03961-3","volume":"25","author":"AM Salehi","year":"2025","unstructured":"Salehi AM, Shahbazi F, Garavand R, Kamkari S, Jenabi E. Global socioeconomic inequalities in breast, cervical, ovarian, and uterine cancers incidence, mortality, disability-adjusted life year\u2019s rates: a relative concentration index analysis. BMC Womens Health. 2025;25(1):433. https:\/\/doi.org\/10.1186\/s12905-025-03961-3.","journal-title":"BMC Womens Health"},{"issue":"11","key":"28608_CR11","doi-asserted-by":"publisher","first-page":"e2443198","DOI":"10.1001\/jamanetworkopen.2024.43198","volume":"7","author":"HM Bizuayehu","year":"2024","unstructured":"Bizuayehu HM, Ahmed KY, Kibret GD, et al. Global Disparities of Cancer and Its Projected Burden in 2050. JAMA Netw Open. 2024;7(11):e2443198\u20132443198. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.43198.","journal-title":"JAMA Netw Open"},{"key":"28608_CR12","doi-asserted-by":"publisher","first-page":"04155","DOI":"10.7189\/jogh.14.04155","volume":"14","author":"B Zhu","year":"2024","unstructured":"Zhu B, Gu H, Mao Z, et al. Global burden of gynaecological cancers in 2022 and projections to 2050. J Glob Health. 2024;14:04155. https:\/\/doi.org\/10.7189\/jogh.14.04155.","journal-title":"J Glob Health"},{"key":"28608_CR13","unstructured":"Ferlay JEM, Lam F et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.who.int\/today. 2024."},{"key":"28608_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33588","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021. https:\/\/doi.org\/10.1002\/ijc.33588.","journal-title":"Int J Cancer"},{"issue":"10440","key":"28608_CR15","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/s0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361. https:\/\/doi.org\/10.1016\/s0140-6736(24)00757-8.","journal-title":"Lancet"},{"key":"28608_CR16","doi-asserted-by":"publisher","unstructured":"Global. burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2100\u20132132. https:\/\/doi.org\/10.1016\/s0140-6736(24)00367-2","DOI":"10.1016\/s0140-6736(24)00367-2"},{"issue":"2","key":"28608_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/03014460.2019.1707872","volume":"47","author":"A Bell","year":"2020","unstructured":"Bell A. Age period cohort analysis: a review of what we should and shouldn\u2019t do. Ann Hum Biol. 2020;47(2):208\u201317. https:\/\/doi.org\/10.1080\/03014460.2019.1707872.","journal-title":"Ann Hum Biol"},{"issue":"11","key":"28608_CR18","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.Epi-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2296\u2013302. https:\/\/doi.org\/10.1158\/1055-9965.Epi-14-0300.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"28608_CR19","unstructured":"Ferlay J, Laversanne M, Ervik M. Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.who.int\/tomorrow,. 2024."},{"key":"28608_CR20","volume-title":"Cancer Mortality for Selected Sites in 24 Countries (1950\u20131957)","author":"M Segi","year":"1960","unstructured":"Segi M, Susumu F. Cancer Mortality for Selected Sites in 24 Countries (1950\u20131957). Sendai: Department of Public Health Tohoku University School of Medicine; 1960."},{"key":"28608_CR21","doi-asserted-by":"publisher","unstructured":"Doll R, Payne P, Waterhouse J. Cancer Incidence in Five Continents: A Technical Report. Springer-Verlag, Berlin. 1966; https:\/\/doi.org\/10.1007\/978-3-642-85849-9","DOI":"10.1007\/978-3-642-85849-9"},{"issue":"8","key":"28608_CR22","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/s1470-2045(19)30340-7","volume":"20","author":"NR Nen\u00e9","year":"2019","unstructured":"Nen\u00e9 NR, Reisel D, Leimbach A, et al. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. Lancet Oncol. 2019;20(8):1171\u201382. https:\/\/doi.org\/10.1016\/s1470-2045(19)30340-7.","journal-title":"Lancet Oncol"},{"issue":"1","key":"28608_CR23","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.3802\/jgo.2024.35.e31","volume":"35","author":"HI Ha","year":"2024","unstructured":"Ha HI, Kim JH, Lim J, Song YJ, Won YJ, Lim MC. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea. J Gynecol Oncol. 2024;35(1):e31. https:\/\/doi.org\/10.3802\/jgo.2024.35.e31.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"28608_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/igc.0000000000000858","volume":"27","author":"K Ojamaa","year":"2017","unstructured":"Ojamaa K, Veerus P, Baburin A, Everaus H, Innos K. Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage. Int J Gynecol Cancer. 2017;27(1):44\u20139. https:\/\/doi.org\/10.1097\/igc.0000000000000858.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"28608_CR25","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.31557\/apjcp.2022.23.4.1415","volume":"23","author":"E Leong","year":"2022","unstructured":"Leong E, Ong SK, Jali F, Naing L, Incidence. Mortality and Survival Analysis of Epithelial Ovarian Cancer in Brunei Darussalam. Asian Pac J Cancer Prev. 2022;23(4):1415\u201323. https:\/\/doi.org\/10.31557\/apjcp.2022.23.4.1415.","journal-title":"Asian Pac J Cancer Prev"},{"key":"28608_CR26","doi-asserted-by":"publisher","first-page":"102253","DOI":"10.1016\/j.canep.2022.102253","volume":"81","author":"CL Velayo","year":"2022","unstructured":"Velayo CL, Reforma KN, Sicam RVG, Diwa MH, Sy ADR, Tantengco OAG. Improving diagnostic strategies for ovarian cancer in Filipino women using ultrasound imaging and a multivariate index assay. Cancer Epidemiol. 2022;81:102253. https:\/\/doi.org\/10.1016\/j.canep.2022.102253.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"28608_CR27","doi-asserted-by":"publisher","first-page":"e2254595","DOI":"10.1001\/jamanetworkopen.2022.54595","volume":"6","author":"A Gupta","year":"2023","unstructured":"Gupta A, Chen Q, Wilson LE, et al. Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation. JAMA Netw Open. 2023;6(2):e2254595. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.54595.","journal-title":"JAMA Netw Open"},{"key":"28608_CR28","doi-asserted-by":"publisher","first-page":"100436","DOI":"10.1016\/j.jcpo.2023.100436","volume":"38","author":"A Znaor","year":"2023","unstructured":"Znaor A, Ryzhov A, Losada ML, et al. Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey. J Cancer Policy. 2023;38:100436. https:\/\/doi.org\/10.1016\/j.jcpo.2023.100436.","journal-title":"J Cancer Policy"},{"key":"28608_CR29","doi-asserted-by":"crossref","unstructured":"Zhuang Q, Gu G, Chen J et al. Global, regional, and national burden of ovarian cancer among young women during 1990\u20132019. Eur J Cancer Prev. 2025;34(1).","DOI":"10.1097\/CEJ.0000000000000899"},{"key":"28608_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canep.2019.06.005","volume":"61","author":"AW Lee","year":"2019","unstructured":"Lee AW, Navajas EE, Liu L. Clear differences in ovarian cancer incidence and trends by ethnicity among Asian Americans. Cancer Epidemiol. 2019;61:142\u20139. https:\/\/doi.org\/10.1016\/j.canep.2019.06.005.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"28608_CR31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12905-025-03904-y","volume":"25","author":"B Jiang","year":"2025","unstructured":"Jiang B. Analysis of global ovarian cancer disease burden and its changing trend from 1990 to 2021. BMC Womens Health. 2025;25(1):352. https:\/\/doi.org\/10.1186\/s12905-025-03904-y.","journal-title":"BMC Womens Health"},{"key":"28608_CR32","doi-asserted-by":"publisher","first-page":"101662","DOI":"10.1016\/j.eclinm.2022.101662","volume":"53","author":"HL Xu","year":"2022","unstructured":"Xu HL, Gong TT, Liu FH, et al. Artificial intelligence performance in image-based ovarian cancer identification: A systematic review and meta-analysis. EClinicalMedicine. 2022;53:101662. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101662.","journal-title":"EClinicalMedicine"},{"key":"28608_CR33","doi-asserted-by":"publisher","unstructured":"Dai W-L, Wu Y-N, Ling Y-T, et al. Development and validation of a deep learning pipeline to diagnose ovarian masses using ultrasound screening: a retrospective multicenter study. eClinicalMedicine. 2024;78. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102923.","DOI":"10.1016\/j.eclinm.2024.102923"},{"issue":"7","key":"28608_CR34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/ijgc-2021-003103","volume":"32","author":"E Olkhov-Mitsel","year":"2022","unstructured":"Olkhov-Mitsel E, Lu F-I, Gagliardi A, Plotkin A. Gynecologic pathology services in low- and middle-income countries. Int J Gynecol Cancer. 2022;32(7):918\u201323. https:\/\/doi.org\/10.1136\/ijgc-2021-003103.","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"28608_CR35","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.31557\/apjcp.2019.20.12.3563","volume":"20","author":"JY Hwang","year":"2019","unstructured":"Hwang JY, Lim WY, Tan CS, et al. Ovarian Cancer Incidence in the Multi-Ethnic Asian City-State of Singapore 1968\u20132012. Asian Pac J Cancer Prev. 2019;20(12):3563\u20139. https:\/\/doi.org\/10.31557\/apjcp.2019.20.12.3563.","journal-title":"Asian Pac J Cancer Prev"},{"key":"28608_CR36","doi-asserted-by":"crossref","unstructured":"Sapkota S, Abhyankar A, Dessai S. Ovarian cancer practice survey from the South Asian Association for Regional Cooperation (SAARC) Nations. Cancer Res Stat Treat. 2019;2(2).","DOI":"10.4103\/CRST.CRST_41_19"},{"issue":"5","key":"28608_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.ejso.2020.11.012","volume":"47","author":"SJ Park","year":"2021","unstructured":"Park SJ, Lee EJ, Lee TS, et al. Asian perspective on debulking surgery for advanced ovarian cancer: An E-survey. Eur J Surg Oncol. 2021;47(5):1111\u20136. https:\/\/doi.org\/10.1016\/j.ejso.2020.11.012.","journal-title":"Eur J Surg Oncol"},{"key":"28608_CR38","doi-asserted-by":"publisher","first-page":"100156","DOI":"10.1016\/j.obpill.2024.100156","volume":"13","author":"M Riaz","year":"2025","unstructured":"Riaz M, Lodhi S, Beyond BMI. Exploring obesity trends in the south Asian region. Obes Pillars. 2025;13:100156. https:\/\/doi.org\/10.1016\/j.obpill.2024.100156.","journal-title":"Obes Pillars"},{"issue":"11","key":"28608_CR39","doi-asserted-by":"publisher","first-page":"e0003888","DOI":"10.1371\/journal.pgph.0003888","volume":"4","author":"V Quintero Santofimio","year":"2024","unstructured":"Quintero Santofimio V, Amaral AFS, Feary J. Occupational exposures in low- and middle-income countries: A scoping review. PLOS Glob Public Health. 2024;4(11):e0003888. https:\/\/doi.org\/10.1371\/journal.pgph.0003888.","journal-title":"PLOS Glob Public Health"},{"issue":"10177","key":"28608_CR40","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/s0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240\u201353. https:\/\/doi.org\/10.1016\/s0140-6736(18)32552-2.","journal-title":"Lancet"},{"issue":"11","key":"28608_CR41","doi-asserted-by":"publisher","first-page":"e1618","DOI":"10.1002\/cnr2.1618","volume":"5","author":"B Ellwanger","year":"2022","unstructured":"Ellwanger B, Sch\u00fcler-Toprak S, Jochem C, Leitzmann MF, Baurecht H. Anthropometric factors and the risk of ovarian cancer: A systematic review and meta-analysis. Cancer Rep (Hoboken). 2022;5(11):e1618. https:\/\/doi.org\/10.1002\/cnr2.1618.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"3","key":"28608_CR42","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/ijc.32322","volume":"146","author":"CJ Cabasag","year":"2020","unstructured":"Cabasag CJ, Arnold M, Butler J, et al. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Int J Cancer. 2020;146(3):749\u201358. https:\/\/doi.org\/10.1002\/ijc.32322.","journal-title":"Int J Cancer"},{"key":"28608_CR43","doi-asserted-by":"publisher","first-page":"1414968","DOI":"10.3389\/fendo.2024.1414968","volume":"15","author":"H Xiang","year":"2024","unstructured":"Xiang H, Wang L, Sun L, Xu S. The risk of ovarian cancer in hormone replacement therapy users: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024;15:1414968. https:\/\/doi.org\/10.3389\/fendo.2024.1414968.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"28608_CR44","doi-asserted-by":"publisher","first-page":"1647757","DOI":"10.3389\/fonc.2025.1647757","volume":"15","author":"B Yin","year":"2025","unstructured":"Yin B, Zhou H. Burden and trends of ovarian and uterine cancer due to high body mass index from 1990 to 2021: an age-period-cohort study based on the GBD 2021, and projections through 2036. Front Oncol. 2025;15:1647757. https:\/\/doi.org\/10.3389\/fonc.2025.1647757.","journal-title":"Front Oncol"},{"issue":"5","key":"28608_CR45","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1158\/1055-9965.Epi-24-1143","volume":"34","author":"LJ Collin","year":"2025","unstructured":"Collin LJ, Cushing-Haugen KL, Terry KL, et al. Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes. Cancer Epidemiol Biomarkers Prev. 2025;34(5):762\u201373. https:\/\/doi.org\/10.1158\/1055-9965.Epi-24-1143.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"28608_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12905-024-02884-9","volume":"24","author":"M Azangou-Khyavy","year":"2024","unstructured":"Azangou-Khyavy M, Ghasemi E, Rezaei N, et al. Global, regional, and national quality of care index of cervical and ovarian cancer: a systematic analysis for the global burden of disease study 1990\u20132019. BMC Womens Health. 2024;24(1):69. https:\/\/doi.org\/10.1186\/s12905-024-02884-9.","journal-title":"BMC Womens Health"},{"issue":"1","key":"28608_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13148-023-01584-9","volume":"15","author":"AS Avramenko","year":"2023","unstructured":"Avramenko AS, Flanagan JM. An epigenetic hypothesis for ovarian cancer prevention by oral contraceptive pill use. Clin Epigenetics. 2023;15(1):165. https:\/\/doi.org\/10.1186\/s13148-023-01584-9.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"28608_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ajog.2021.01.014","volume":"225","author":"LH Schrijver","year":"2021","unstructured":"Schrijver LH, Antoniou AC, Olsson H, et al. Oral contraceptive use and ovarian cancer risk for BRCA1\/2 mutation carriers: an international cohort study. Am J Obstet Gynecol. 2021;225(1):51. e1-51.e17.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"28608_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/humupd\/dmac038","volume":"29","author":"MHD van Bommel","year":"2023","unstructured":"van Bommel MHD, IntHout J, Veldmate G, et al. Contraceptives and cancer risks in BRCA1\/2 pathogenic variant carriers: a systematic review and meta-analysis. Hum Reprod Update. 2023;29(2):197\u2013217. https:\/\/doi.org\/10.1093\/humupd\/dmac038.","journal-title":"Hum Reprod Update"},{"issue":"11","key":"28608_CR50","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/ijc.30676","volume":"140","author":"SB Coburn","year":"2017","unstructured":"Coburn SB, Bray F, Sherman ME, Trabert B. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer. 2017;140(11):2451\u201360. https:\/\/doi.org\/10.1002\/ijc.30676.","journal-title":"Int J Cancer"},{"issue":"6","key":"28608_CR51","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jaccao.2025.07.008","volume":"7","author":"C Hull Sarah","year":"2025","unstructured":"Hull Sarah C, Mszar R, Ostfeld Robert J, et al. Diet and Prevention of Cardiovascular Disease and Cancer. JACC: CardioOncology. 2025;7(6):649\u201367. https:\/\/doi.org\/10.1016\/j.jaccao.2025.07.008.","journal-title":"JACC: CardioOncology"},{"issue":"4","key":"28608_CR52","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.ajcnut.2025.02.004","volume":"121","author":"CM Nagle","year":"2025","unstructured":"Nagle CM, Ibiebele TI, Na R, et al. Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association Consortium. Am J Clin Nutr. 2025;121(4):758\u201368. https:\/\/doi.org\/10.1016\/j.ajcnut.2025.02.004.","journal-title":"Am J Clin Nutr"},{"key":"28608_CR53","doi-asserted-by":"publisher","unstructured":"Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management. Cancers. 2023;15(2). https:\/\/doi.org\/10.3390\/cancers15020485.","DOI":"10.3390\/cancers15020485"},{"key":"28608_CR54","doi-asserted-by":"crossref","unstructured":"Kang SY, Kim Y-J, Kim S, Park HS. Different Patterns of the Relationship Between Gynecological Malignancy and Obesity Index: A Nationwide Retrospective Cohort Study in Korea. J Korean Med Sci. 2025;40(11).","DOI":"10.3346\/jkms.2025.40.e31"},{"issue":"7","key":"28608_CR55","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/oby.23464","volume":"30","author":"TPT Tran","year":"2022","unstructured":"Tran TPT, Luu NM, Bui TT, Han M, Lim MK, Oh JK. Weight-change trajectory in relation to cancer risk: findings from a nationwide cohort study in South Korea. Obes (Silver Spring). 2022;30(7):1507\u201319. https:\/\/doi.org\/10.1002\/oby.23464.","journal-title":"Obes (Silver Spring)"},{"issue":"2","key":"28608_CR56","doi-asserted-by":"publisher","first-page":"e71541","DOI":"10.1002\/cam4.71541","volume":"15","author":"X Li","year":"2026","unstructured":"Li X, Fu G, Liu Z, Li J, Shan D. Ovarian Cancer and High Body-Mass Index: A Global Burden of Disease Database Study From 1990 to 2021. Cancer Med. 2026;15(2):e71541. https:\/\/doi.org\/10.1002\/cam4.71541.","journal-title":"Cancer Med"},{"issue":"3","key":"28608_CR57","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.3802\/jgo.2019.30.e23","volume":"30","author":"ZY Liu","year":"2019","unstructured":"Liu ZY, Gao XP, Zhu S, et al. Dietary inflammatory index and risk of gynecological cancers: a systematic review and meta-analysis of observational studies. J Gynecol Oncol. 2019;30(3):e23. https:\/\/doi.org\/10.3802\/jgo.2019.30.e23.","journal-title":"J Gynecol Oncol"},{"key":"28608_CR58","doi-asserted-by":"publisher","unstructured":"Ko\u0142akowska K, Ki\u015bluk J, Nikli\u0144ski J. A Novel Insight into the Role of Obesity-Related Adipokines in Ovarian Cancer-State-of-the-Art Review and Future Perspectives. Int J Mol Sci. 2025;26(5). https:\/\/doi.org\/10.3390\/ijms26051857.","DOI":"10.3390\/ijms26051857"},{"key":"28608_CR59","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.2147\/cmar.S303707","volume":"13","author":"Q Yang","year":"2021","unstructured":"Yang Q, Yu B, Kang J, Li A, Sun J. Obesity Promotes Tumor Immune Evasion in Ovarian Cancer Through Increased Production of Myeloid-Derived Suppressor Cells via IL-6. Cancer Manag Res. 2021;13:7355\u201363. https:\/\/doi.org\/10.2147\/cmar.S303707.","journal-title":"Cancer Manag Res"},{"key":"28608_CR60","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2147\/jir.S294368","volume":"14","author":"E Cohen","year":"2021","unstructured":"Cohen E, Margalit I, Shochat T, Goldberg E, Krause I. Markers of Chronic Inflammation in Overweight and Obese Individuals and the Role of Gender: A Cross-Sectional Study of a Large Cohort. J Inflamm Res. 2021;14:567\u201373. https:\/\/doi.org\/10.2147\/jir.S294368.","journal-title":"J Inflamm Res"},{"issue":"10","key":"28608_CR61","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.4239\/wjd.v14.i10.1463","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Akbari-Alavijeh S, Parhar RS, Gaugler R, Hashmi S. Partners in diabetes epidemic: A global perspective. World J Diabetes. 2023;14(10):1463\u201377. https:\/\/doi.org\/10.4239\/wjd.v14.i10.1463.","journal-title":"World J Diabetes"},{"key":"28608_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70568","author":"N Wiebe","year":"2026","unstructured":"Wiebe N, Thompson S, Stenvinkel P, Bello A, James MT, Tonelli M. Associations of obesity, systemic inflammation, and hyperinsulinemia with the incidence of non-communicable chronic disease and mortality: A prospective cohort study. Diabetes Obes Metab. 2026. https:\/\/doi.org\/10.1111\/dom.70568.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"28608_CR63","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ygyno.2016.10.005","volume":"143","author":"ER Craig","year":"2016","unstructured":"Craig ER, Londo\u00f1o AI, Norian LA, Arend RC. Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A review. Gynecol Oncol. 2016;143(3):674\u201383. https:\/\/doi.org\/10.1016\/j.ygyno.2016.10.005.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"28608_CR64","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1289\/ehp.1003283","volume":"119","author":"MC Camargo","year":"2011","unstructured":"Camargo MC, Stayner LT, Straif K, et al. Occupational exposure to asbestos and ovarian cancer: a meta-analysis. Environ Health Perspect. 2011;119(9):1211\u20137. https:\/\/doi.org\/10.1289\/ehp.1003283.","journal-title":"Environ Health Perspect"},{"issue":"1","key":"28608_CR65","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/ijgc-2020-001672","volume":"31","author":"B Slomovitz","year":"2021","unstructured":"Slomovitz B, de Haydu C, Taub M, Coleman RL, Monk BJ. Asbestos and ovarian cancer: examining the historical evidence. Int J Gynecol Cancer. 2021;31(1):122\u20138. https:\/\/doi.org\/10.1136\/ijgc-2020-001672.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"28608_CR66","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/1471-0528.17283","volume":"130","author":"R Manchanda","year":"2023","unstructured":"Manchanda R, Sideris M. Population-based genetic testing for cancer susceptibility genes: quo vadis? BJOG. 2023;130(2):125\u201330. https:\/\/doi.org\/10.1111\/1471-0528.17283.","journal-title":"BJOG"},{"key":"28608_CR67","doi-asserted-by":"publisher","first-page":"101017","DOI":"10.1016\/j.lanwpc.2024.101017","volume":"44","author":"WK Ho","year":"2024","unstructured":"Ho WK, Hassan NT, Yoon SY, et al. Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants - an Asian study of 572 families. Lancet Reg Health West Pac. 2024;44:101017. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101017.","journal-title":"Lancet Reg Health West Pac"},{"issue":"6","key":"28608_CR68","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jama.2024.9210","volume":"332","author":"ME Barnard","year":"2024","unstructured":"Barnard ME, Farland LV, Yan B, et al. Endometriosis Typology and Ovarian Cancer Risk. JAMA. 2024;332(6):482\u20139. https:\/\/doi.org\/10.1001\/jama.2024.9210.","journal-title":"JAMA"},{"issue":"2","key":"28608_CR69","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/ije\/dyt042","volume":"42","author":"W Sieh","year":"2013","unstructured":"Sieh W, Salvador S, McGuire V, et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol. 2013;42(2):579\u201389. https:\/\/doi.org\/10.1093\/ije\/dyt042.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"28608_CR70","doi-asserted-by":"publisher","first-page":"e2523434","DOI":"10.1001\/jamanetworkopen.2025.23434","volume":"8","author":"MK Abel","year":"2025","unstructured":"Abel MK, Mazina V, Bregar AJ, et al. Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer. JAMA Netw Open. 2025;8(7):e2523434\u20132523434. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.23434.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"28608_CR71","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1097\/mjt.0000000000001584","volume":"30","author":"A Bryant","year":"2023","unstructured":"Bryant A, Johnson E, Grayling M, et al. Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis. Am J Ther. 2023;30(1):e36\u201355. https:\/\/doi.org\/10.1097\/mjt.0000000000001584.","journal-title":"Am J Ther"},{"issue":"7","key":"28608_CR72","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1158\/1055-9965.Epi-25-0120","volume":"34","author":"K Agbedinu","year":"2025","unstructured":"Agbedinu K, Antwi S, Aduse-Poku L, et al. A Scoping Review on Barriers to Cancer Diagnosis and Care in Low- and Middle-Income Countries. Cancer Epidemiol Biomarkers Prev. 2025;34(7):1066\u201373. https:\/\/doi.org\/10.1158\/1055-9965.Epi-25-0120.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"28608_CR73","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s12672-025-02205-y","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chang L, He H, et al. The impact of the COVID-19 pandemic on the diagnosis, treatment, and prognosis of ovarian cancer in the United States: a retrospective cohort study based on the SEER database. Discov Oncol. 2025;16(1):545. https:\/\/doi.org\/10.1007\/s12672-025-02205-y.","journal-title":"Discov Oncol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28608-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28608-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28608-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:02:28Z","timestamp":1792422148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28608-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28608"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28608-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"3003"}}